Real-world experience with cefiderocol therapy for Pseudomonas aeruginosa and other multidrug resistant gram-negative infections within the Veterans Health Administration, 2019–2022

OBJECTIVE: Single-center and regional studies have reported outcomes after treatment with cefiderocol, a novel siderophore cephalosporin. We report on real-world use, clinical outcomes, and microbiological outcomes with cefiderocol therapy within the Veterans’ Health Administration (VHA). DESIGN: Pr...

Descripción completa

Detalles Bibliográficos
Autores principales: Chou, Andrew, Ramsey, David, Amenta, Eva, Trautner, Barbara W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cambridge University Press 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10173288/
https://www.ncbi.nlm.nih.gov/pubmed/37179761
http://dx.doi.org/10.1017/ash.2023.165

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10173288/
https://www.ncbi.nlm.nih.gov/pubmed/37179761
http://dx.doi.org/10.1017/ash.2023.165

Ejemplares similares